- Home
- Publications
- Publication Search
- Publication Details
Title
Defining a role for laquinimod in multiple sclerosis
Authors
Keywords
-
Journal
Therapeutic Advances in Neurological Disorders
Volume 7, Issue 4, Pages 195-205
Publisher
SAGE Publications
Online
2014-04-09
DOI
10.1177/1756285614529615
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine
- (2013) Fatemeh Hemmati et al. BEHAVIOURAL BRAIN RESEARCH
- Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis
- (2013) Valérie Jolivel et al. BRAIN
- Teriflunomide for the Treatment of Multiple Sclerosis
- (2013) Jiwon Oh et al. SEMINARS IN NEUROLOGY
- Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
- (2012) Wolfgang Brück et al. ACTA NEUROPATHOLOGICA
- Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod
- (2012) Manoj K. Mishra et al. AMERICAN JOURNAL OF PATHOLOGY
- Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis
- (2012) Elias Toubi et al. JOURNAL OF NEUROIMMUNOLOGY
- Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis
- (2012) Francesca Ruffini et al. Multiple Sclerosis Journal
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
- (2012) Ulf Schulze-Topphoff et al. PLoS One
- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- Multiple Sclerosis: Pathogenesis and Treatment
- (2011) Ingrid Loma et al. Current Neuropharmacology
- Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis
- (2011) Jan Thöne et al. Expert Opinion on Drug Metabolism & Toxicology
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
- (2010) Christiane Wegner et al. JOURNAL OF NEUROIMMUNOLOGY
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study
- (2010) G. Comi et al. Multiple Sclerosis Journal
- Tratamiento oral con laquinimod en la esclerosis múltiple
- (2010) O. Fernández NEUROLOGIA
- Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
- (2009) Per Björk et al. PLOS BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started